Stockreport

ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split

CONTRAVIR PHARMACEUTICALS INC  (CTRV) 
US:NASDAQ Investor Relations: ir.contravir.com/investor-relations
PDF EDISON, N.J., May 31, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV), a biopharmaceutical company focused on the development of therapeutic dr [Read more]